Parkinsonism: preliminary report on two new antiparkinsonian agents.
D000978:Antiparkinson Agents; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000628:therapy*; D020734:Parkinsonian Disorders; D010640:Phenothiazines / Q000031:analogs & derivatives
D000978:Antiparkinson Agents; D009125:Muscle Relaxants, Central; D010640:Phenothiazines; C031637:phenothiazine
MUSCLE RELAXANTS/therapeutic use; PARALYSIS AGITANS/therapy; PHENOTHIAZINE/derivatives